When Fenofibrate was administered orally as an aqueous suspension to rats, it was found that Fenofibrate formulated as a nanosuspension by the DissoCube process had equivalent dissolution and bioavailability compared to the Fenofibrate formulated as a microsuspension in Simple Syrup NF
When Fenofibrate was administered orally as an aqueous suspension to rats, it was found that Fenofibrate formulated as a nanosuspension by the DissoCube process had equivalent dissolution and bioavailability compared to the Fenofibrate formulated as a microsuspension in Simple Syrup NF
When Fenofibrate was administered orally as an aqueous suspension to rats, it was found that Fenofibrate formulated as a nanosuspension by the DissoCube process had equivalent dissolution and bioavailability compared to the Fenofibrate formulated as a microsuspension in Simple Syrup NF A: 正确 B: 错误
When Fenofibrate was administered orally as an aqueous suspension to rats, it was found that Fenofibrate formulated as a nanosuspension by the DissoCube process had equivalent dissolution and bioavailability compared to the Fenofibrate formulated as a microsuspension in Simple Syrup NF A: 正确 B: 错误
1